Mark R. Openshaw
Impact in
-
- Cancer Genomics and Diagnostics
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 9
- Cancer Cells and Metastasis 3
- Cancer Treatment and Pharmacology 2
-
- Cancer Genomics and Diagnostics 9
- Co-authors
- Jacqui Shaw (7 shared papers)Heather Knight (1 shared paper)David W. Galbraith (1 shared paper)David S. Guttery (6 shared papers)Marc R. Knight (1 shared paper)Michael K. Deyholos (1 shared paper)Gareth Warren (1 shared paper)Karen Page (3 shared papers)
- Journals
- European Journal of Surgical Oncology (2 papers)Expert Review of Molecular Diagnostics (2 papers)npj Genomic Medicine (1 paper)The Plant Journal (1 paper)Clinical Genitourinary Cancer (1 paper)
- Partner nations
- United KingdomItalyBelgium
In The Last Decade
Mark R. Openshaw
25 papers receiving 364 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 84
- Hepatology 31
- Oncology 59
- Pathology and Forensic Medicine 31
- Plant Science 72
Countries citing papers authored by Mark R. Openshaw
This map shows the geographic impact of Mark R. Openshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Openshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Openshaw more than expected).
Fields of papers citing papers by Mark R. Openshaw
This network shows the impact of papers produced by Mark R. Openshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Openshaw. The network helps show where Mark R. Openshaw may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark R. Openshaw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 77 | |
| 2 | 2023 | 38 | |
| 3 | 2020 | 36 | |
| 4 | 2020 | 34 | |
| 5 | 2010 | 25 | |
| 6 | 2021 | 24 | |
| 7 | 2015 | 24 | |
| 8 | 2016 | 20 | |
| 9 | 2008 | 13 | |
| 10 | 2023 | 12 | |
| 11 | 2022 | 11 | |
| 12 | 2017 | 9 | |
| 13 | 2015 | 8 | |
| 14 | 2011 | 7 | |
| 15 | 2020 | 6 | |
| 16 | 2022 | 6 | |
| 17 | 2023 | 5 | |
| 18 | 2023 | 3 | |
| 19 | 2018 | 3 | |
| 20 | 2019 | 3 |
About Mark R. Openshaw
Mark R. Openshaw is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health and Surgery, having authored 30 papers that have together received 370 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Genetic factors in colorectal cancer (4 papers), Cancer Cells and Metastasis (3 papers), Gestational Trophoblastic Disease Studies (3 papers), Prenatal Screening and Diagnostics (3 papers), Cancer Treatment and Pharmacology (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Autoimmune Bullous Skin Diseases (2 papers). The work is most often cited by research in Cancer Research (84 citations), Hepatology (31 citations), Oncology (59 citations), Pathology and Forensic Medicine (31 citations) and Plant Science (72 citations). Mark R. Openshaw has collaborated with scholars based in United Kingdom, Italy and Belgium. Frequent co-authors include Jacqui Shaw, Heather Knight, David W. Galbraith, David S. Guttery, Marc R. Knight, Michael K. Deyholos, Gareth Warren, Karen Page, Daniel Fernández-García and David J. Pinato. Their work appears in journals such as European Journal of Surgical Oncology, Expert Review of Molecular Diagnostics, npj Genomic Medicine, The Plant Journal and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.